A carregar...
Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
BACKGROUND: The ongoing global malaria eradication campaign requires development of potent, safe, and cost-effective drugs lacking cross-resistance with existing chemotherapies. One critical step in drug development is selecting a suitable clinical candidate from late leads. The process used to sele...
Na minha lista:
| Publicado no: | Malar J |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7893776/ https://ncbi.nlm.nih.gov/pubmed/33608015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-021-03617-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|